Amedisys (AMED) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Amedisys Reports Third Quarter Financial Results
October 29, 2014 7:00 AM EDTBATON ROUGE, La., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Amedisys, Inc. (Nasdaq: AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2014.
Three-Month Periods Ended September 30, 2014 and 2013
After adding back for the 2014 period, $1.0 million ($0.6 million, net of income tax) or $0.02 per diluted share and for the 2013 period $145.0 million ($90.2 million, net of income tax) or $2.86 per diluted share for certain items*, our adjusted results from continuing operations were as follows: Net service revenue of $300.3 million compared to $301.3 million in 2013. Net income from... More